| Literature DB >> 35159623 |
Mónica Quintero1, Maria José Santander2, Sebastián Velásquez1, Julián Zapata3, Mónica P Cala2.
Abstract
In this study, we aimed to apply an untargeted LC/QTOF-MS analysis for the identification of compounds that positively and negatively affect the acceptance of coffee beverages from liquid coffee concentrates (CLCs) before and after storage. The metabolomic results were integrated with physicochemical and sensory parameters, such as color, pH, titratable acidity, and oxygen contents, by a bootstrapped version of partial least squares discriminant analysis (PLS-DA) to select and classify the most relevant variables regarding the rejection or acceptance of CLC beverages. The OPLS-DA models for metabolite selection discriminated between the percent sensory acceptance (the Accepted group) and rejection (the Rejected group). Eighty-two molecular features were considered statistically significant. Our data suggest that coffee sample rejection is associated with chlorogenic acid hydrolysis to produce ferulic and quinic acids, consequently generating methoxybenzaldehydes that impact the perceived acidity and aroma. Furthermore, acceptance was correlated with higher global scores and sweetness, as with lactones such as feruloyl-quinolactone, caffeoyl quinolactone, and 4-caffeoyl-1,5-quinolactone, and significant oxygen levels in the headspace.Entities:
Keywords: concentrated liquid coffee; high-performance liquid chromatography; mass spectrometry; sensory analysis; untargeted metabolomics
Year: 2022 PMID: 35159623 PMCID: PMC8834377 DOI: 10.3390/foods11030473
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1PCA score plots for untargeted metabolomics in both positive and negative ESI modes. (Green dots, accepted samples (n = 6); blue dots, rejected samples (n = 6); dark red dots, quality control samples, QC.) (A) LC-QTOF-MS (+) with QC samples: R2(cum): 0.853, Q2 (cum): 0.847. (B) LC-QTOF-MS (−) with QC samples: R2(cum): 0.873, Q2 (cum): 0.841. (C) LC-QTOF-MS (+): R2(cum): 0.629, Q2 (cum): 0.386. (D) LC-QTOF-MS (−): R2(cum): 0.701, Q2 (cum): 0.428.
Figure 2Comparison of the supervised OPLS-DA models for untargeted metabolomics of rejected samples (n = 6) vs. accepted samples (n = 6). (Green dots, accepted samples (n = 6); blue dots, rejected samples (n = 6)). (A): Positive ESI mode comparison LC-QTOF-MS (+): R2X(cum): 0.394, R2Y(cum):0.0965, Q2 (cum): 0.691, CV-ANOVA: 0.056. (B) Negative ESI mode—LC-QTOF-MS (−): R2X(cum): 0.868, R2Y(cum): 0.997, Q2 (cum): 0.974, CV-ANOVA: 0.00063.
Metabolites significantly differentiated between the Accepted and Rejected groups using both ESI modes by untargeted metabolomics via quadrupole time-of-flight mass spectrometry (GM-LC/MS-QTOF).
| Compound | Formula | Mass | RT (min) | Mass Error (ppm) | Adduct | CVforQC (%) a | DET | CON | Rejected vs. Accepted Samples | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Change (%) b | VIP c | ||||||||||
| Cytosine | C4H5N3O | 111.0433 | 1.59 | 7 | M+H | 3.3 | ESI+ | Putative | −55 | 1.5155 | 0.0086 |
| Methylfuran-carboxylic acid | C6H6O3 | 126.0317 | 4.45 | 5 | M+H-H2O | 4.3 | ESI+ | Putative | −173 | 2.3476 | 0.0338 * |
| Octene-diynoic acid | C8H6O2 | 134.0368 | 7.01 | 4 | M+H-H2O | 1.8 | ESI+ | Putative | 29 | 1.5942 | 0.0649 |
| Hydroxy-methylbenzaldehyde | C8H8O2 | 136.0524 | 11.33 | 5 | M-H | 2.8 | ESI− | Putative | 61 | 1.6083 | 0.0275 * |
| Methoxybenzaldehyde | C8H8O2 | 136.0524 | 6.29 | 2 | M-H | 2.9 | ESI− | Putative | 17 | 1.7607 | 0.0275 * |
| Vinylcatechol | C8H8O2 | 136.0524 | 9.52 | 4 | M-H | 3.7 | ESI− | Putative | 49 | 1.8414 | 0.0086 |
| Hydroxyphenethylamine | C8H11NO | 137.0841 | 11.52 | 4 | M+H-H2O | 6.3 | ESI+ | MSMS | 82 | 1.0769 | 0.0151 |
| Benzofurancarboxaldehyde | C9H6O2 | 146.0368 | 8.27 | 4 | M+H | 1.4 | ESI+ | Putative | 29 | 1.4441 | 0.0411 |
| Cinnamic acid | C9H8O2 | 148.0524 | 8.95 | 5 | M+H | 1.6 | ESI+ | Putative | 44 | 1.2417 | 0.0151 |
| (Furanyl)-tetrahydropyridine | C9H11NO | 149.0841 | 1.57 | 5 | M+H | 3.4 | ESI+ | Putative | −97 | 1.5258 | 0.0510 * |
| Ethylnicotinate | C8H9NO2 | 151.0633 | 2.26 | 3 | M+H | 13.7 | ESI+ | Putative | −130 | 1.6802 | 0.0086 |
| Furfurylpyrrolidine | C9H13NO | 151.0997 | 6.29 | 4 | M+H-H2O | 5.8 | ESI+ | Putative | 93 | 1.8865 | 0.0338 * |
| Methoxybenzoic acid | C8H8O3 | 152.0473 | 8.42 | 3 | M+H-H2O | 2.5 | ESI+ | Putative | 109 | 1.6151 | 0.0510 * |
| Hydroxycoumarin | C9H6O3 | 162.0317 | 11.84 | 3 | M-H | 8.5 | ESI− | MSMS | −92 | 3.4280 | 0.0275 * |
| Pyridoxal | C8H9NO3 | 167.0582 | 1.51 | 5 | M+H | 3.4 | ESI+ | Putative | 90 | 1.6302 | 0.0338 * |
| Carboline | C11H8N2 | 168.0687 | 10.30 | 5 | M+H | 1.3 | ESI+ | Putative | −29 | 1.1236 | 0.0411 |
| Isovalerylalanine | C8H15NO3 | 173.1052 | 2.60 | 16 | M+Na | 3.1 | ESI+ | Putative | −101 | 1.1844 | 0.0151 |
| Methyl-quinolin-diol | C10H9NO2 | 175.0633 | 8.24 | 4 | M+H | 2.1 | ESI+ | Putative | −78 | 2.3966 | 0.0510 * |
| (Cyclohexylmethyl)pyrazine | C11H16N2 | 176.1313 | 3.53 | 1 | M+K | 1.8 | ESI+ | Putative | 52 | 1.0421 | 0.0649 |
| [2H-Pyrrol-(3H)-ylidenemethyl]-furanmethanol | C10H11NO2 | 177.0790 | 6.94 | 3 | M+H-H2O | 1.4 | ESI+ | Putative | −65 | 1.2231 | 0.0151 |
| Dimethyl-(1-pyrrolidinyl)-cyclopenten-one | C11H17NO | 179.1310 | 8.88 | 5 | M+H | 3.6 | ESI+ | Putative | −130 | 1.0109 | 0.0510 * |
| Caffeic acid | C9H8O4 | 180.0423 | 8.90 | 3 | M+H-H2O | 8.0 | ESI+/− | Identified | 37 | 1.0605 | 0.1320 |
| Hydroxy-(hydroxyphenyl)propenoicacid | C9H8O4 | 180.0423 | 14.69 | 3 | M+H-H2O | 1.9 | ESI+ | Putative | −27 | 1.5147 | 0.1320 |
| Indole-propionic acid | C11H11NO2 | 189.0790 | 11.14 | 4 | M+H | 4.9 | ESI+ | Putative | −102 | 1.3162 | 0.0338 * |
| Quinic acid | C7H12O6 | 192.0634 | 6.09 | 1 | M-H | 1.7 | ESI− | MSMS | 16 | 1.5511 | 0.0086 |
| Ferulic acid | C10H10O4 | 194.0579 | 10.57 | 3 | M+H-H2O | 6.0 | ESI+ | Putative | 161 | 1.5558 | 0.0338 * |
| (Furan+B63:B75yl)-hexahydro-7H-cyclopenta[b]pyridinone | C12H13NO2 | 203.0946 | 5.51 | 3 | M+H | 5.9 | ESI+ | Putative | −173 | 1.6442 | 0.0338 * |
| Methylsalicyluric acid | C10H11NO4 | 209.0688 | 1.33 | 3 | M+H | 5.2 | ESI+ | Putative | 1918 | 2.5034 | 0.0338 * |
| 1-Isothiocyanato-8-(methylthio)octane | C10H19NS2 | 217.0959 | 3.64 | 10 | M+Na | 5.5 | ESI+ | Putative | 1011 | 1.6326 | 0.0338 * |
| 1-Arabinofuranosylcytosine | C9H13N3O5 | 243.0895 | 4.40 | 20 | M+H | 9.1 | ESI+ | Putative | 199 | 1.0998 | 0.0086 |
| 243,0895@8,74 | - | 243.0895 | 8.74 | - | M+H | 4.8 | ESI+ | Putative | −95 | 1.0254 | 0.0510 * |
| Hydroxy-(hydroxy-methyl-hexenyl)benzofuran | C15H18O3 | 246.1256 | 5.01 | 2 | M+Na | 2.8 | ESI+ | Putative | −328 | 2.5216 | 0.0338 * |
| N-Phenylacetylasparticacid | C12H13NO5 | 251.0794 | 3.12 | 2 | M+H-H2O | 5.2 | ESI+ | MSMS | −254 | 2.2707 | 0.0338 * |
| N-Pyruvoyl-methoxy-hydroxyanthranilate | C11H11NO6 | 253.0586 | 1.36 | 3 | M+H | 3.2 | ESI+ | Putative | 1860 | 1.9896 | 0.0338 * |
| N,N’-Diphenyl-phenylenediamine | C18H16N2 | 260.1313 | 1.67 | 10 | M+Cl | 3.6 | ESI− | Putative | 25 | 1.0798 | 0.0086 |
| 268,1064@5,01 * | - | 268.1064 | 5.01 | - | M+H | 5.6 | ESI+ | Putative | −328 | 2.5216 | 0.0338 * |
| Evoxanthidine | C15H11NO4 | 269.0688 | 4.40 | 7 | M+H | 3.5 | ESI+ | Putative | 207 | 1.2801 | 0.0338 * |
| Trichostachine | C16H17NO3 | 271.1208 | 7.32 | 3 | M+H | 10.9 | ESI+ | Putative | 218 | 1.4652 | 0.0338 * |
| Deaminofusarochromanone | C15H19NO4 | 277.1314 | 5.13 | 3 | M+H | 5.7 | ESI+ | MSMS | 68 | 1.2220 | 0.0151 |
| Eriodictyol | C15H12O6 | 288.0634 | 11.34 | 1 | M-H | 3.9 | ESI− | MSMS | 34 | 1.0096 | 0.0275 * |
| 317,0903@3,49 | - | 295.1088 | 3.49 | - | - | 1.6 | ESI+ | MSMS | 94 | 1.1685 | 0.0510 * |
| ent-Hydroxybuphanisine | C17H19NO4 | 301.1314 | 6.93 | 3 | M+H | 4.4 | ESI+ | Putative | 205 | 1.9999 | 0.0338 * |
| 291,1111@7,49 | - | 309.1212 | 7.49 | - | M+H | 4.2 | ESI+ | Putative | −189 | 1.1515 | 0.0411 |
| O-p-Coumaroyl-D-glucose | C15H18O8 | 326.1002 | 5.74 | 1 | M-H-H2O | 2.6 | ESI− | Putative | 192 | 1.0547 | 0.0275 * |
| Guaiacin | C20H24O4 | 328.1675 | 17.17 | 2 | M+H | 6.5 | ESI+ | Putative | −197 | 2.3579 | 0.0338 * |
| 331.215@13.47 | C20H29NO3 | 331.2147 | 13.47 | 3 | M+H | 3.2 | ESI+ | Putative | −102 | 1.1645 | 0.0338 * |
| 5-O-Caffeoylshikimicacid//4-Caffeoyl-1,5-quinolactone * | C16H16O8 | 336.0845 | 12.84 | 1 | M-H | 6 | ESI− | Putative | −100 | 2.4478 | 0.0275 * |
| Caffeoyl-quinolactone | C16H16O8 | 336.0845 | 11.32 | 3 | M+H | 5.6 | ESI+/− | Putative | −422 | 4.4402 | 0.0338 * |
| O-Caffeoylshikimicacid | C16H16O8 | 336.0845 | 11.84 | 0 | M-H | 2.1 | ESI− | Putative | −87 | 5.6218 | 0.0275 * |
| Feruloyl-quinolactone * | C17H18O8 | 350.1002 | 13.86 | 1 | M-H | 5.8 | ESI− | Putative | −82 | 3.3243 | 0.0275 * |
| Chlorogenic acid | C16H18O9 | 354.0951 | 8.42 | 1 | M-H | 2.7 | ESI− | Identified | 21 | 2.4680 | 0.0086 |
| Cryptochlorogenic acid | C16H18O9 | 354.0951 | 9.75 | 2 | M-H-H2O | 2.1 | ESI− | Identified | −77 | 2.9124 | 0.0275 * |
| Neochlorogenic acid | C16H18O9 | 354.0951 | 6.29 | 3 | M+H | 5.0 | ESI+/− | Identified | 106 | 1.1735 | 0.0086 |
| O-beta-D-Glucopyranuronosyl-D-mannose | C12H20O12 | 356.0955 | 1.38 | 1 | M-H-H2O | 2.8 | ESI− | Putative | −23 | 1.1169 | 0.0150 |
| N-Caffeoyltryptophan | C20H18N2O5 | 366.4000 | 1.37 | 1 | M-H | 4.2 | ESI− | Putative | −29 | 1.5959 | 0.0275 * |
| Piperundecalidine | C23H29NO3 | 367.2147 | 18.79 | 7 | M+H | 6.9 | ESI+ | Putative | −276 | 1.3874 | 0.0338 * |
| O-Feruloylquinicacid | C17H20O9 | 368.1107 | 8.64 | 0 | M-H | 3.7 | ESI− | Putative | 30 | 1.2937 | 0.0275 * |
| Pentamethoxyflavanone | C20H22O7 | 374.1366 | 18.72 | 1 | M+FA-H | 3.7 | ESI− | Putative | −48 | 1.0967 | 0.0275 * |
| 412.1014@8.70 * | C31H12N2 | 412.1000 | 8.70 | 1 | M-H | 3.6 | ESI− | Putative | −73 | 1.1022 | 0.0275 * |
| 439.1852@7.47//ValHisTyr | C20H27N5O5 | 417.2012 | 7.47 | 6 | M+Na | 14.3 | ESI+ | Putative | −543 | 1.8897 | 0.0338 * |
| ValHisTyr | C20H27N5O5 | 417.2012 | 5.94 | 6 | M+Na | 9.2 | ESI+ | Putative | −499 | 2.0702 | 0.0338 * |
| 447,1498@4,01 | - | 447.1498 | 4.01 | - | M+H | 5.0 | ESI+ | Putative | −30 | 1.0433 | 0.4848 |
| (+)-CatechinC-glucoside | C21H24O11 | 452.1319 | 16.70 | 2 | M-H-H2O | 3.9 | ESI− | Putative | −39 | 1.0612 | 0.0275 * |
| 481,138@11,29 | - | 459.1529 | 11.29 | - | M+H | 7.2 | ESI+ | Putative | 14895 | 1.2221 | 0.0338 * |
| N-[(Dihydropterinyl)methyl]-(beta-D-ribofuranosyl)anilinephosphate | C18H23N6O8P | 482.1315 | 3.91 | 8 | M-H-H2O | 2.0 | ESI− | Putative | −31 | 1.2776 | 0.0275 * |
| 482,2526@15,50 | - | 482.2526 | 15.50 | - | M-H | 2.7 | ESI− | Putative | −26 | 1.4000 | 0.0275 * |
| 498,3072@18,79 | - | 498.3072 | 18.79 | - | - | 2.1 | ESI+ | Putative | −245 | 2.7344 | 0.0338 * |
| Aconine | C25H41NO9 | 499.2781 | 12.24 | 3 | M+H | 2.5 | ESI+ | Putative | 21 | 1.3575 | 0.2402 |
| Galactomannan | C18H32O16 | 504.1690 | 1.59 | 1 | M+H-H2O | 2.9 | ESI+ | MSMS | −108 | 1.0085 | 0.1796 |
| Cafamarine | C26H36O10 | 508.2308 | 17.19 | 0 | M+FA-H | 5.3 | ESI− | Putative | −38 | 1.6678 | 0.0275 * |
| Dicaffeoylquinicacid | C25H24O12 | 516.1268 | 7.92 | 2 | M+H | 6.3 | ESI+ | MSMS | 65 | 1.2450 | 0.0338 * |
| Di-O-caffeoylquinicacid//Dicaffeoylquinicacid | C25H24O12 | 516.1268 | 8.91 | 3 | M+H | 4.6 | ESI+ | Putative | 46 | 1.0344 | 0.1320 |
| 528,1487@8,70 | - | 528.1487 | 8.70 | - | M-H | 4.2 | ESI− | Putative | −35 | 1.2142 | 0.0275 * |
| PC(22:1) | C30H58NO8P | 591.3900 | 18.76 | 4 | M+Na | 10.9 | ESI+ | Putative | −73 | 1.3013 | 0.0510 * |
| Kaempferiderhamnoside-(succinylglucoside) | C32H36O18 | 708.1902 | 7.97 | 2 | M+H-H2O | 5.9 | ESI+ | Putative | 84 | 1.3239 | 0.0086 |
| 726,4535@18,99 | - | 726.4535 | 18.99 | - | M-H | 3.4 | ESI− | Putative | −26 | 2.2514 | 0.0275 * |
| PS(39:7) | C45H74NO10P | 819.5050 | 18.79 | 7 | M+Na | 5.3 | ESI+ | Putative | −96 | 1.2246 | 0.0151 |
| PC(DiMe(9,3)/MonoMe(11,3)) | C45H79NO10P | 824.5442 | 17.98 | 6 | M+H | 2.6 | ESI+ | Putative | −115 | 1.0803 | 0.0510 * |
| PI(33:0) | C42H81O13P | 825.5461 | 18.06 | 3 | M+H | 4 | ESI+ | Putative | −132 | 1.1234 | 0.0338 * |
a CV, coefficient of variation in the metabolites in the QC samples; b Change, percent change in the abundance of the specified comparison calculated as (case-control)/control) * 100, where the sign indicates the direction of change in the case group; c VIP, variable importance in projection; d p value * corresponding to the p values calculated by the Benjamini–Hochberg false discovery rate post hoc correction (FDR < 0.05). GM: global metabolomics, LC: liquid chromatography, QTOF-MS: quadrupole time-of-flight mass spectrometry.
Means and standard deviations of the studied physicochemical properties and oxygen features for accepted samples (n = 6) and rejected samples (n = 6).
| Acceptance Group | ||
|---|---|---|
| Parameter | Accepted Samples | Rejected Samples |
| Physicochemical | ||
| Titratable acidity | 59.93 ± 4.69 a | 72.19 ± 3.25 b |
| Concentration [°Bx] | 35.96 ± 0.56 a | 35.65 ± 0.26 a |
| pH | 4.79 ± 0.16 a | 4.76 ± 0.10 a |
| Chroma * | 27.92 ± 1.99 b | 25.09 ± 1.94 a |
| a* | 20.47 ± 1.30 b | 16.80 ± 1.39 a |
| b* | 18.96 ± 1.86 a | 18.63 ± 1.42 a |
| L* | 12.59 ± 1.14 a | 13.05 ± 0.78 a |
| Hue | 0.75 ± 0.04 a | 0.84 ± 0.02 b |
| Oxygen and carbon dioxide | ||
| O2—HS | 7.63 ± 7.79 b | 0.30 ± 0.02 a |
| CO2—HS | 29.37 ± 16.89 a | 40.48 ± 5.35 b |
| O2—Dissolved | 0.24 ± 0.09 a | 0.27 ± 0.06 a |
| O2—Saturation | 3.08 ± 0.97 a | 3.76 ± 0.8 b |
* Chroma corresponds to the relationship between the color changes in the red (+a*) to green (−a*) ratio and the blue (−b*) to yellow (+b*) ratio, represented by a* and b*, respectively.
Figure 3A box plot representing the sensory profiles of the evaluated samples to compare the acceptability associated with the Accepted and Rejected groups.
Figure 4Bootstrapped PLS-DA biplot for acceptance classification. (A) Score plot for the averaged PLS-DA model for the first two latent variables, and (B) the loadings and selectivity ratio (bubble area) for the physicochemical, sensory, ESI−, and ESI+ datasets for the bootstrapped PLS-DA for acceptance classification.